Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients

Nephrology Dialysis Transplantation

Volumn 28, Issue 3, 2013, Pages 632-640

  Di Iorio, Biagio R ^a   Bellizzi, Vincenzo ^b   Bellasi, Antonio ^c   Torraca, Serena ^a   D'Arrigo, Graziella ^d   Tripepi, Giovanni ^d   Zoccali, Carmine ^d  

^a A Landolfi Hospital   (Italy)

^b UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Chronic kidney disease; Phosphate intake; Proteinuria

Indexed keywords

ALANINE DERIVATIVE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM KETOALANINE; CALCIUM KETOISOLEUCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; ISOLEUCINE; PHOSPHATE; SODIUM; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIET SUPPLEMENTATION; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATURIA; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEINURIA; REFERENCE VALUE; SODIUM URINE LEVEL; THERAPY EFFECT; VERY LOW PROTEIN DIET;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHATES; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84874854530     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs477     Document Type: Article

References (39)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
2. Jafar TH, Stark PC, Schmid CH et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001; 60: 1131-1140
3. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-615
4. Ibels LS, Alfrey AC, Haut L et al. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 1978; 298: 122-126
5. Neves KR, Graciolli FG, dos Reis LM et al. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004; 66: 2237-2244
6. Barsotti G, Morelli E, Giannoni A et al. Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial. Kidney Int Suppl 1983; 16: S278-S284
7. Norris KC, Greene T, Kopple J et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 2006; 17: 2928-2936
8. Schwarz S, Trivedi BK, Kalantar-Zadeh K et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 825-831
9. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916
10. Bellasi A, Mandreoli M, Baldrati L et al. Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 2011; 6: 883-891
11. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-659
12. Gansevoort RT, De Zeeuw D, de Jong PE. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 1995; 10: 497-504
13. Chauveau P, Combe C, Rigalleau V et al. Restricted protein diet is associated with decrease in proteinuria: consequences on the progression of renal failure. J Ren Nutr 2007; 17: 250-257
14. Di Iorio BR, Cucciniello E, Martino R et al. Acute and persistent antiproteinuric effect of a low-protein diet in chronic kidney disease. G Ital Nefrol 2009; 26: 608-615 (Italian)
15. Aparicio M, Bouchet JL, Gin H et al. Effect of a low-protein diet on urinary albumin excretion in uremic patients. Nephron 1988; 50: 288-291
16. Barsotti G, Navalesi R, Giampietro O et al. Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with 'overt' diabetic nephropathy and renal insufficiency. Contrib Nephrol 1988; 65: 87-94
17. Barsotti G, Cupisti A, Morelli E et al. Vegan supplemented diet in nephrotic syndrome. Nephrol Dial Transplant 1990; 5 (Suppl 1): 75-77
18. Lee H, Oh SW, Heo NJ et al. Serum phosphorus as a predictor of low-grade albuminuria in a general population without evidence of chronic kidney disease. Nephrol Dial Transplant 2012; 27: 2799-2806
19. Zoccali C, Ruggenenti P, Perna A et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011; 22: 1923-1930
20. Bellizzi V, Di Iorio BR, Brunori G et al. Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire- based survey. J Ren Nutr 2010; 20: 82-90
21. Bellizzi V, De Nicola L, Di Iorio B. Restriction of dietary protein and long-term outcomes in patients with CKD. Am J Kidney Dis 2009; 54: 183-184
22. Di Iorio BR, Minutolo R, De Nicola L et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 2003; 64: 1822-1828
23. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2008; 145: 247-254
24. Remuzzi A, Perticucci E, Battaglia C et al. Low-protein diet and glomerular size-selective function in membranous glomerulopathy. Am J Kidney Dis 1991; 17: 317-322
25. Willimas PS, Stevens ME, Fass G et al. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure. A prospective, randomized, controlled trial. Q J Med 1991; 81: 837-855
26. Gutierrez OM. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Clin J Am Soc Nephrol 2010; 5: 1710-1716
27. Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
28. Mirza MA, Hansen T, Johansson L et al. Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 2009; 24: 3125-3131
29. Mirza MA, Larsson A, Melhus H et al. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009; 207: 546-551
30. Fliser D, Kollerits B, Neyer U et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18: 2600-2608
31. Wolf M, Molnar MZ, Amaral AP et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 2011; 22: 956-966
32. Seiler S, Heine GH, Fliser D. Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl 2009; 76: S34-S42
33. Tang L, Both K, Taylor R. ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle. Vasc Med 1999; 4: 129-134
34. Shuto E, Taketani Y, Tanaka R et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009; 20: 1504-1512
35. Cianciaruso B, Pota A, Pisani A et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5: a randomized controlled trial. Nephrol Dial Transplant 2008; 23: 636-644
36. Fouque D, Pelletier S, Mafra D et al. Nutrition and chronic kidney disease. Kidney Int 2011; 80: 348-357
37. Gonzalez-Parra E, Gracia-Iguacel C, Egido J et al. Phosphorus and nutrition in chronic kidney disease. Int J Nephrol 2012; doi:10.155/2012/597605.
38. Slagman MC, Waanders F, Hemmelder MH et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. Br Med J 2011; 343: d4366
39. Heerspink HJ, Holtkamp FA, Parving HH et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 2012; 82: 330-337